30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Ligand Pharmaceuticals Inc (LGND)

Track

Over the last 90 days, Ligand Pharmaceuticals Inc. has seen significant insider selling, with a net value of approximately -$4.7 million. The total number of insider transactions was 63, with a net decrease of 5 insiders. Notable recent transactions include multiple large proposed and actual sales by directors and other insiders, totaling over $16 million in sell value.
Stock chart
Ticker: LGND Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Sabba Stephen L
1 sale — total 100,000 USD
Sale 16 Jun 2026
Value US$2,078,323.10 | Price 69.35 | Shares 34,968
Proposed sale 16 Jun 2026
Value US$4,280,064.37 | Price 307.04 | Shares 79,130
Sale 12 Jun 2026
Value US$100,000.00 | Price 256.08 | Shares 1,000
Sale 12 Jun 2026
Value US$100,000.00 | Price 255.01 | Shares 1,000
Proposed sale 12 Jun 2026
Value US$100,000.00 | Price 256.00 | Shares 1,000
Sale 11 Jun 2026
Value US$100,000.00 | Price 250.00 | Shares 1,000
Proposed sale 11 Jun 2026
Value US$100,000.00 | Price 249.97 | Shares 1,000
Sale 10 Jun 2026
Value US$100,000.00 | Price 251.62 | Shares 1,000
Sale 10 Jun 2026
Value US$100,000.00 | Price 249.53 | Shares 1,000
Sale 10 Jun 2026
Value US$100,000.00 | Price 248.11 | Shares 1,000
Sale 10 Jun 2026
Value US$100,000.00 | Price 247.22 | Shares 1,000
Sale 10 Jun 2026
Value US$100,000.00 | Price 250.00 | Shares 1,000
Proposed sale 10 Jun 2026
Value US$100,000.00 | Price 249.96 | Shares 1,000
Proposed sale 10 Jun 2026
Value US$100,000.00 | Price 249.35 | Shares 1,000
Proposed sale 10 Jun 2026
Value US$100,000.00 | Price 250.88 | Shares 1,000
Planned sale 1 Jun 2026
Value US$46,082.00 | Price 230.41 | Shares 200
Planned sale 1 Jun 2026
Value US$279,032.60 | Price 229.47 | Shares 1,216
Planned sale 1 Jun 2026
Value US$133,487.10 | Price 228.57 | Shares 584
Planned sale 1 Jun 2026
Value US$90,711.76 | Price 226.78 | Shares 400
Planned sale 1 Jun 2026
Value US$323,585.03 | Price 225.97 | Shares 1,432
Planned sale 1 Jun 2026
Value US$152,459.25 | Price 225.20 | Shares 677
Planned sale 1 Jun 2026
Value US$109,957.83 | Price 223.95 | Shares 491
Sale 13 May 2026
Value US$352,012.50 | Price 223.50 | Shares 1,575
Proposed sale 13 May 2026
Value US$352,012.50 | Price 223.50 | Shares 1,575
Sale 12 May 2026
Value US$102,816.00 | Price 224.00 | Shares 459
Proposed sale 12 May 2026
Value US$102,816.00 | Price 224.00 | Shares 459
Planned sale 1 May 2026
Value US$27,153.89 | Price 234.09 | Shares 116
Planned sale 1 May 2026
Value US$24,419.89 | Price 232.57 | Shares 105
Planned sale 1 May 2026
Value US$38,258.07 | Price 231.87 | Shares 165
Planned sale 1 May 2026
Value US$229.87 | Price 229.87 | Shares 1
Planned sale 1 May 2026
Value US$18,189.40 | Price 227.37 | Shares 80
Proposed sale 1 May 2026
Value US$107,349.29 | Price 229.87 | Shares 467
Planned sale 1 May 2026
Value US$187,214.16 | Price 234.02 | Shares 800
Planned sale 1 May 2026
Value US$330,749.24 | Price 232.92 | Shares 1,420
Planned sale 1 May 2026
Value US$180,991.12 | Price 232.04 | Shares 780
Planned sale 1 May 2026
Value US$85,421.60 | Price 230.87 | Shares 370
Planned sale 1 May 2026
Value US$22,511.44 | Price 229.71 | Shares 98
Planned sale 1 May 2026
Value US$213,198.45 | Price 228.75 | Shares 932
Planned sale 1 May 2026
Value US$136,469.58 | Price 227.45 | Shares 600
Planned sale 1 Apr 2026
Value US$68,917.38 | Price 204.50 | Shares 337
Planned sale 1 Apr 2026
Value US$68,917.38 | Price 204.50 | Shares 337
Planned sale 1 Apr 2026
Value US$195,702.59 | Price 203.22 | Shares 963
Planned sale 1 Apr 2026
Value US$195,702.59 | Price 203.22 | Shares 963
Planned sale 1 Apr 2026
Value US$141,327.97 | Price 201.90 | Shares 700
Planned sale 1 Apr 2026
Value US$141,327.97 | Price 201.90 | Shares 700
Planned sale 1 Apr 2026
Value US$248,767.31 | Price 200.94 | Shares 1,238
Planned sale 1 Apr 2026
Value US$248,767.31 | Price 200.94 | Shares 1,238
Planned sale 1 Apr 2026
Value US$260,038.17 | Price 199.72 | Shares 1,302
Planned sale 1 Apr 2026
Value US$260,038.17 | Price 199.72 | Shares 1,302
Planned sale 1 Apr 2026
Value US$91,470.68 | Price 198.85 | Shares 460
Planned sale 1 Apr 2026
Value US$91,470.68 | Price 198.85 | Shares 460
Planned sale 1 Apr 2026
Value US$32,477.77 | Price 204.26 | Shares 159
Planned sale 1 Apr 2026
Value US$32,477.77 | Price 204.26 | Shares 159
Planned sale 1 Apr 2026
Value US$8,725.22 | Price 202.91 | Shares 43
Planned sale 1 Apr 2026
Value US$8,725.22 | Price 202.91 | Shares 43
Planned sale 1 Apr 2026
Value US$15,991.36 | Price 202.42 | Shares 79
Planned sale 1 Apr 2026
Value US$15,991.36 | Price 202.42 | Shares 79
Planned sale 1 Apr 2026
Value US$8,049.40 | Price 201.24 | Shares 40
Planned sale 1 Apr 2026
Value US$8,049.40 | Price 201.24 | Shares 40
Planned sale 1 Apr 2026
Value US$29,196.34 | Price 199.97 | Shares 146
Planned sale 1 Apr 2026
Value US$29,196.34 | Price 199.97 | Shares 146
Proposed sale 1 Apr 2026
Value US$95,034.50 | Price 203.50 | Shares 467
Sale 23 Mar 2026
Value US$207,872.70 | Price 207.87 | Shares 1,000
Proposed sale 23 Mar 2026
Value US$207,872.70 | Price 207.87 | Shares 1,000
Planned sale 11 Mar 2026
Value US$687,825.00 | Price 225.00 | Shares 3,057
Proposed sale 11 Mar 2026
Value US$648,970.53 | Price 212.29 | Shares 3,057
Sale 6 Mar 2026
Value US$433,842.36 | Price 200.76 | Shares 2,161
Proposed sale 6 Mar 2026
Value US$433,842.36 | Price 200.76 | Shares 2,161
Planned sale 4 Mar 2026
Value US$238,532.28 | Price 208.87 | Shares 1,142
Planned sale 4 Mar 2026
Value US$300,939.06 | Price 208.12 | Shares 1,446
Planned sale 4 Mar 2026
Value US$126,689.45 | Price 207.01 | Shares 612
Planned sale 4 Mar 2026
Value US$70,164.78 | Price 206.37 | Shares 340
Planned sale 4 Mar 2026
Value US$94,381.88 | Price 205.18 | Shares 460
Planned sale 4 Mar 2026
Value US$40,834.00 | Price 204.17 | Shares 200
Planned sale 4 Mar 2026
Value US$60,510.00 | Price 201.70 | Shares 300
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-18 2026-06-16 S Sale
3.9
Sabba Stephen L
Non-Executive Director
34,968 +25.6%
69.35
US$2,078,323 		34,968 +25.6% 69.35 US$2,078,323
2026-06-16 2026-06-16 PrS Proposed sale
3.9
STEPHEN L. SABBA

Director

Non-Executive Director
79,130
307.04
US$4,280,064 		79,130 307.04 US$4,280,064
2026-06-15 2026-06-12 S Sale
1.4
Haas Jason
Non-Executive Director
45,267 +31.1%
444.21
US$3,735,462 		45,267 +31.1% 444.21 US$3,735,462
2026-06-15 2026-06-12 S Sale
1.4
Haas Jason
Non-Executive Director
1,000 -26.2%
255.01
US$100,000 		1,000 -26.2% 255.01 US$100,000
2026-06-12 2026-06-12 PrS Proposed sale
1.4
JASON HAAS

Director

Non-Executive Director
1,000
256.00
US$100,000 		1,000 256.00 US$100,000
2026-06-12 2026-06-11 S Sale
2.4
Aryeh Jason
Non-Executive Director
1,000 -4.2%
250.00
US$100,000 		1,000 -4.2% 250.00 US$100,000
2026-06-11 2026-06-11 PrS Proposed sale
2.4
Aryeh Jason

Director

Non-Executive Director
1,000
249.97
US$100,000 		1,000 249.97 US$100,000
2026-06-12 2026-06-10 S Sale
3.7
LAMATTINA JOHN L
Non-Executive Director
1,000 -11.2%
251.62
US$100,000 		1,000 -11.2% 251.62 US$100,000
2026-06-12 2026-06-10 S Sale
3.7
LAMATTINA JOHN L
Non-Executive Director
1,000 -2.2%
249.53
US$100,000 		1,000 -2.2% 249.53 US$100,000
2026-06-12 2026-06-10 S Sale
3.7
LAMATTINA JOHN L
Non-Executive Director
1,000 -0.7%
248.11
US$100,000 		1,000 -0.7% 248.11 US$100,000
2026-06-12 2026-06-10 S Sale
3.7
LAMATTINA JOHN L
Non-Executive Director
1,000 -0.8%
247.22
US$100,000 		1,000 -0.8% 247.22 US$100,000
2026-06-12 2026-06-10 S Sale
2.4
Aryeh Jason
Non-Executive Director
1,000 -0.5%
250.00
US$100,000 		1,000 -0.5% 250.00 US$100,000
2026-06-10 2026-06-10 PrS Proposed sale
2.4
Aryeh Jason

Director

Non-Executive Director
1,000
249.96
US$100,000 		1,000 249.96 US$100,000
2026-06-10 2026-06-10 PrS Proposed sale
3.7
JOHN L LAMATTINA

Director

Non-Executive Director
1,000
250.88
US$100,000 		1,000 250.88 US$100,000
2026-06-10 2026-06-10 PrS Proposed sale
2.4
Aryeh Jason

Director

Non-Executive Director
1,000
249.35
US$100,000 		1,000 249.35 US$100,000
2026-06-02 2026-06-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
200 -0.5%
230.41
US$46,082 		200 -0.5% 230.41 US$46,082
2026-06-02 2026-06-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,216 -2.8%
229.47
US$279,033 		1,216 -2.8% 229.47 US$279,033
2026-06-02 2026-06-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
584 -1.3%
228.57
US$133,487 		584 -1.3% 228.57 US$133,487
2026-06-02 2026-06-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
400 -0.9%
226.78
US$90,712 		400 -0.9% 226.78 US$90,712
2026-06-02 2026-06-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,432 -3.2%
225.97
US$323,585 		1,432 -3.2% 225.97 US$323,585
2026-06-02 2026-06-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
677 -1.5%
225.20
US$152,459 		677 -1.5% 225.20 US$152,459
2026-06-02 2026-06-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
491 -1.1%
223.95
US$109,958 		491 -1.1% 223.95 US$109,958
2026-05-14 2026-05-13 S Sale
3.4
KOZARICH JOHN W
Non-Executive Director
1,575 -3.6%
223.50
US$352,012 		1,575 -3.6% 223.50 US$352,012
2026-05-13 2026-05-13 PrS Proposed sale
3.4
JOHN KOZARICH

Director

Non-Executive Director
1,575
223.50
US$352,012 		1,575 223.50 US$352,012
2026-05-14 2026-05-12 S Sale
3.4
KOZARICH JOHN W
Non-Executive Director
459 -1.1%
224.00
US$102,816 		459 -1.1% 224.00 US$102,816
2026-05-12 2026-05-12 PrS Proposed sale
3.4
JOHN KOZARICH

Director

Non-Executive Director
459
224.00
US$102,816 		459 224.00 US$102,816
2026-05-14 2026-05-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
116 -0.3%
234.09
US$27,154 		116 -0.3% 234.09 US$27,154
2026-05-14 2026-05-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
105 -0.2%
232.57
US$24,420 		105 -0.2% 232.57 US$24,420
2026-05-14 2026-05-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
165 -0.4%
231.87
US$38,258 		165 -0.4% 231.87 US$38,258
2026-05-14 2026-05-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
1 -0.0%
229.87
US$230 		1 -0.0% 229.87 US$230
2026-05-14 2026-05-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
80 -0.2%
227.37
US$18,189 		80 -0.2% 227.37 US$18,189
2026-05-04 2026-05-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
800 -1.9%
234.02
US$187,214 		800 -1.9% 234.02 US$187,214
2026-05-04 2026-05-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,420 -3.3%
232.92
US$330,749 		1,420 -3.3% 232.92 US$330,749
2026-05-04 2026-05-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
780 -1.8%
232.04
US$180,991 		780 -1.8% 232.04 US$180,991
2026-05-04 2026-05-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
370 -0.8%
230.87
US$85,422 		370 -0.8% 230.87 US$85,422
2026-05-04 2026-05-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
98 -0.2%
229.71
US$22,511 		98 -0.2% 229.71 US$22,511
2026-05-04 2026-05-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
932 -2.0%
228.75
US$213,198 		932 -2.0% 228.75 US$213,198
2026-05-04 2026-05-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
600 -1.3%
227.45
US$136,470 		600 -1.3% 227.45 US$136,470
2026-05-01 2026-05-01 PrS Proposed sale
3.4
KOZARICH JOHN W

Director

Non-Executive Director
467
229.87
US$107,349 		467 229.87 US$107,349
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
337 -0.8%
204.50
US$68,917 		337 -0.8% 204.50 US$68,917
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
337 -0.8%
204.50
US$68,917 		337 -0.8% 204.50 US$68,917
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
963 -2.3%
203.22
US$195,703 		963 -2.3% 203.22 US$195,703
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
963 -2.3%
203.22
US$195,703 		963 -2.3% 203.22 US$195,703
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
700 -1.6%
201.90
US$141,328 		700 -1.6% 201.90 US$141,328
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
700 -1.6%
201.90
US$141,328 		700 -1.6% 201.90 US$141,328
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,238 -2.8%
200.94
US$248,767 		1,238 -2.8% 200.94 US$248,767
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,238 -2.8%
200.94
US$248,767 		1,238 -2.8% 200.94 US$248,767
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,302 -2.8%
199.72
US$260,038 		1,302 -2.8% 199.72 US$260,038
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,302 -2.8%
199.72
US$260,038 		1,302 -2.8% 199.72 US$260,038
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
460 -1.0%
198.85
US$91,471 		460 -1.0% 198.85 US$91,471
2026-04-02 2026-04-01 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
460 -1.0%
198.85
US$91,471 		460 -1.0% 198.85 US$91,471
2026-04-02 2026-04-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
159 -0.4%
204.26
US$32,478 		159 -0.4% 204.26 US$32,478
2026-04-02 2026-04-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
159 -0.4%
204.26
US$32,478 		159 -0.4% 204.26 US$32,478
2026-04-02 2026-04-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
43 -0.1%
202.91
US$8,725 		43 -0.1% 202.91 US$8,725
2026-04-02 2026-04-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
43 -0.1%
202.91
US$8,725 		43 -0.1% 202.91 US$8,725
2026-04-02 2026-04-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
79 -0.2%
202.42
US$15,991 		79 -0.2% 202.42 US$15,991
2026-04-02 2026-04-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
79 -0.2%
202.42
US$15,991 		79 -0.2% 202.42 US$15,991
2026-04-02 2026-04-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
40 -0.1%
201.24
US$8,049 		40 -0.1% 201.24 US$8,049
2026-04-02 2026-04-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
40 -0.1%
201.24
US$8,049 		40 -0.1% 201.24 US$8,049
2026-04-02 2026-04-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
146 -0.3%
199.97
US$29,196 		146 -0.3% 199.97 US$29,196
2026-04-02 2026-04-01 PlS Planned sale
3.4
KOZARICH JOHN W
Non-Executive Director
146 -0.3%
199.97
US$29,196 		146 -0.3% 199.97 US$29,196
2026-04-01 2026-04-01 PrS Proposed sale
3.4
KOZARICH JOHN W

Director

Non-Executive Director
467
203.50
US$95,034 		467 203.50 US$95,034
2026-03-25 2026-03-23 S Sale
3.9
Sabba Stephen L
Non-Executive Director
1,000 -3.0%
207.87
US$207,873 		1,000 -3.0% 207.87 US$207,873
2026-03-23 2026-03-23 PrS Proposed sale
3.9
STEPHEN L. SABBA

Director

Non-Executive Director
1,000
207.87
US$207,873 		1,000 207.87 US$207,873
2026-03-13 2026-03-11 PlS Planned sale
2.9
Espinoza Octavio

Chief Financial Officer

Officer
3,057 -12.7%
225.00
US$687,825 		3,057 -12.7% 225.00 US$687,825
2026-03-11 2026-03-11 PrS Proposed sale
2.9
OCTAVIO ESPINOZA

Officer

Officer
3,057
212.29
US$648,971 		3,057 212.29 US$648,971
2026-03-31 2026-03-06 S Sale
3.7
LAMATTINA JOHN L
Non-Executive Director
2,161 -6.6%
200.76
US$433,842 		2,161 -6.6% 200.76 US$433,842
2026-03-06 2026-03-06 PrS Proposed sale
3.7
JOHN L LAMATTINA

Director

Non-Executive Director
2,161
200.76
US$433,842 		2,161 200.76 US$433,842
2026-03-06 2026-03-04 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,142 -3.0%
208.87
US$238,532 		1,142 -3.0% 208.87 US$238,532
2026-03-06 2026-03-04 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
1,446 -3.7%
208.12
US$300,939 		1,446 -3.7% 208.12 US$300,939
2026-03-06 2026-03-04 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
612 -1.5%
207.01
US$126,689 		612 -1.5% 207.01 US$126,689
2026-03-06 2026-03-04 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
340 -0.8%
206.37
US$70,165 		340 -0.8% 206.37 US$70,165
2026-03-06 2026-03-04 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
460 -1.1%
205.18
US$94,382 		460 -1.1% 205.18 US$94,382
2026-03-06 2026-03-04 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
200 -0.5%
204.17
US$40,834 		200 -0.5% 204.17 US$40,834
2026-03-06 2026-03-04 PlS Planned sale
2.3
Reardon Andrew

CLO & Secretary

Officer
300 -0.7%
201.70
US$60,510 		300 -0.7% 201.70 US$60,510
Explore more

More insider trading research around Ligand Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America